DAPT ‘Too Strong’ After CABG for Heart Attacks, Trial Says

By News Health
1 month Ago

(MedPage Today) — MADRID — Dual antiplatelet therapy (DAPT) didn’t improve outcomes after coronary artery bypass grafting (CABG) for an acute coronary syndrome (ACS) but did increase risks, the TACSI randomized trial showed.
With ticagrelor…

Source link : https://www.medpagetoday.com/meetingcoverage/esc/117248

Author :

Publish date : 2025-09-01 20:34:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Is Tylenol Linked to Infant Eczema?

Antibody Prevention of RSV in Infants; Medical Imaging and Cancer Risk in Kids

Trusted Vaccine Guidance Has Collapsed — Along With the Rule of Law

Considering GLP-1 Agonists for Patients With Psoriasis, HS

It's Time to Get a Flu Vaccination. Here's Who Needs One and Why.

Pick GLP-1s as First Drug Option in Obesity, Guidelines From Abroad Say